111 related articles for article (PubMed ID: 6177780)
1. Delineation of immunologically and biochemically distinct HLA-A2 antigens.
Biddison WE; Kostyu DD; Strominger JL; Krangel MS
J Immunol; 1982 Aug; 129(2):730-4. PubMed ID: 6177780
[TBL] [Abstract][Full Text] [Related]
2. The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens.
Biddison WE; Ward FE; Shearer GM; Shaw S
J Immunol; 1980 Feb; 124(2):548-52. PubMed ID: 6153199
[TBL] [Abstract][Full Text] [Related]
3. Differences in HLA antigen recognition by human influenza virus-immune cytotoxic T cells.
Biddison WE; Shaw S
J Immunol; 1979 May; 122(5):1705-9. PubMed ID: 87440
[TBL] [Abstract][Full Text] [Related]
4. Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: evidence for a discrete CTL recognition region.
Krangel MS; Biddison WE; Strominger JL
J Immunol; 1983 Apr; 130(4):1856-62. PubMed ID: 6601143
[TBL] [Abstract][Full Text] [Related]
5. Influenza virus-specific cytotoxic T cells are restricted by multiple HLA-A3-related self antigens: evidence for recognition of distinct self structures in conjunction with different foreign antigens.
Biddison WE; Shearer GM; Shaw S
J Immunol; 1981 Dec; 127(6):2231-5. PubMed ID: 6975312
[TBL] [Abstract][Full Text] [Related]
6. Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules.
Biddison WE; Krangel MS; Strominger JL; Ward FE; Shearer GM; Shaw S
Hum Immunol; 1980 Oct; 1(3):225-32. PubMed ID: 6167549
[TBL] [Abstract][Full Text] [Related]
7. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes.
Ezquerra A; Doménech N; van der Poel J; Strominger JL; Vega MA; López de Castro JA
J Immunol; 1986 Sep; 137(5):1642-9. PubMed ID: 3489037
[TBL] [Abstract][Full Text] [Related]
9. Definition of four HLA-A2 subtypes by CML typing and biochemical analysis.
van der Poel JJ; Mölders H; Thompson A; Ploegh HL
Immunogenetics; 1983; 17(6):609-21. PubMed ID: 6407985
[TBL] [Abstract][Full Text] [Related]
10. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
Hu N; D'Souza C; Cheung H; Lang H; Cheuk E; Chamberlain JW
Vaccine; 2005 Nov; 23(45):5231-44. PubMed ID: 16099553
[TBL] [Abstract][Full Text] [Related]
11. Human cytotoxic T cell responses to trinitrophenyl hapten and influenza virus. Diversity of restriction antigens and specificity of HLA-linked genetic regulation.
Biddison WE; Payne SM; Shearer GM; Shaw S
J Exp Med; 1980 Aug; 152(2 Pt 2):204s-217s. PubMed ID: 6157766
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of the human HLA-A2 or HLA-B7 heavy chain gene and human beta 2-microglobulin gene in L cells.
Bernabeu C; Maziarz R; Spits H; de Vries J; Burakoff SJ; Terhorst C
J Immunol; 1984 Dec; 133(6):3188-94. PubMed ID: 6436376
[TBL] [Abstract][Full Text] [Related]
13. Expression of the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer.
Bernabeu C; Finlay D; van de Rijn M; Maziarz RT; Biro PA; Spits H; de Vries J; Terhorst CP
J Immunol; 1983 Oct; 131(4):2032-7. PubMed ID: 6352810
[TBL] [Abstract][Full Text] [Related]
14. Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes.
Vega MA; Wallace L; Rojo S; Bragado R; Aparicio P; López de Castro JA
J Immunol; 1985 Nov; 135(5):3323-32. PubMed ID: 3930603
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants.
Goulmy E; van Leeuwen A; Blokland E; van Rood JJ; Biddison WE
J Exp Med; 1982 May; 155(5):1567-72. PubMed ID: 6175722
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant.
Taketani S; Krangel MS; Pious D; Strominger JL
J Immunol; 1983 Dec; 131(6):2935-8. PubMed ID: 6196407
[TBL] [Abstract][Full Text] [Related]
17. Two subgroups of HLA Bw44 defined by cell-mediated lympholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium.
Tekolf WA; Biddison WE; Aster RD; Shaw S
J Immunol; 1982 Oct; 129(4):1474-8. PubMed ID: 6180011
[TBL] [Abstract][Full Text] [Related]
18. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes.
Slingluff CL; Cox AL; Henderson RA; Hunt DF; Engelhard VH
J Immunol; 1993 Apr; 150(7):2955-63. PubMed ID: 7681084
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.
Gotch FM; Kelly C; Ellis SA; Wallace L; Rickinson AB; van der Poel J; Crumpton MJ; McMichael AJ
Immunogenetics; 1985; 21(1):11-23. PubMed ID: 2981768
[TBL] [Abstract][Full Text] [Related]
20. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
